Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Curevac N.V. ( (CVAC) ) has released its Q3 earnings. Here is a breakdown of the information Curevac N.V. presented to its investors. CureVac ...
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
ii This approval underscores GSK's commitment to help drive progress for people living with complex blood cancers.
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
GlaxoSmithKline is under pressure from shareholders ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...
Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications. The company, which makes the antacid ...
Teva Pharmaceutical Industries Ltd. ADR 1.52% $19.75B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback